Alta Capital Management LLC Biogen Inc. Transaction History

Alta Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 06, 2020	SELL	$258.66 - $342.55 $664,238 - $879,668	-2,568 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$268.85 - $341.04 $345,203 - $437,895	1,284 Added 100.0%	2,568 $812,000
Q1 2019 Apr 23, 2019	SELL	$216.71 - $338.96 $54,177 - $84,740	-250 Reduced 16.3%	1,284 $303,000
Q4 2018 Jan 09, 2019	SELL	$278.5 - $352.75 $36,205 - $45,857	-130 Reduced 7.81%	1,534 $461,000
Q2 2018 Jul 23, 2018	SELL	$257.52 - $306.91 $55,624 - $66,292	-216 Reduced 11.49%	1,664 $482,000
Q3 2017 Oct 19, 2017	BUY	$281.15 - $329.69 $528,562 - $619,817	1,880	1,880 $588,000

1,050

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Alta Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alta Capital Management LLC with notifications on news.